Platform
Features
Lyra Therapeutics
Contact
Michael Altman was a trader and analyst at First New York Securities from October 2005 to October 2007. Michael is currently a board member at Lyra Therapeutics.
Links
Abacus Medicine
Novo Nordisk
Neuland Laboratories
Oxford PharmaGenesis
Lockwood